Stem cell-based products for veterinary use: specific questions on tumorigenicity to be addressed by Ad Hoc Expert Group on Veterinary Novel Therapies (ADVENT)

Current version

PDF iconProblem statement

Deadline for comments: 30/09/2016

Reference numberEMA/CVMP/ADVENT/207268/2016
Published25/07/2016
Keywordsmesenchymal stem cells (MSCs), veterinary, tumorigenicity, homogeneity, biodistribution, amplification
DescriptionThis problem statement provides the basis for development of a guidance on tumorigenicity in relation to stem cell products intended for veterinary use. If you have any comments on the content of the document, use this . The completed comments form should be sent to vet-guidelines@ema.europa.eu.


Related content


How useful was this page?

Add your rating